monoclonal antibody biosimilar
搜索文档
Zentiva Expands into Biologics with the EU-Wide Launch of Its First Biosimilar
Prnewswire· 2025-12-01 17:00
Accessibility StatementSkip Navigation Logo - https://mma.prnewswire.com/media/2660891/5369762/Zentiva_Logo.jpg SOURCE Zentiva 21% more press release views with Request a Demo Launch marks Zentiva's strategic entry into biosimilars and reinforces its mission to broaden patient access to high-quality biologic medicines across Europe. PRAGUE, Dec. 1, 2025 /PRNewswire/ -- Zentiva, a leading European manufacturer of affordable, high-quality medicines, today announced the first EU-wide launch of a monoclonal ...